A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
<p>Abstract</p> <p>Background</p> <p>Etoricoxib is a highly selective COX-2 inhibitor which was evaluated for the treatment of rheumatoid arthritis (RA).</p> <p>Methods</p> <p>Double-blind, randomized, placebo and active comparator-controlled, 12...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2002-05-01
|
Series: | BMC Family Practice |
Online Access: | http://www.biomedcentral.com/1471-2296/3/10 |